- Home
- KLXE vs ICCM Comparison
KLXE vs ICCM Comparison
Compare KLXE & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | KLXE | ICCM |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.8M | 41.4M |
| IPO Year | 2018 | 2013 |
Fundamental Metrics
Financial Performance| Metric | KLXE | ICCM |
|---|---|---|
| Price | $2.81 | $0.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | ★ 291.4K | 273.6K |
| Earning Date | 03-11-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $636,600,000.00 | N/A |
| Revenue This Year | $3.89 | $53.39 |
| Revenue Next Year | $4.95 | $174.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.46 | $0.54 |
| 52 Week High | $3.74 | $1.40 |
Technical Indicators
Market Signals| Indicator | KLXE | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 55.13 | 45.34 |
| Support Level | $1.59 | $0.58 |
| Resistance Level | $3.09 | $0.74 |
| Average True Range (ATR) | 0.29 | 0.05 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 58.00 | 12.76 |
Price Performance
Historical ComparisonAbout KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.